ロード中...
Phase II, Randomized, Placebo-controlled, 90-day Study of Emixustat HCL in Geographic Atrophy Associated with Dry Age-Related Macular Degeneration
PURPOSE: This study assessed the safety, tolerability, and pharmacodynamics of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD). METHODS: Subjects were randomly assigned to oral emi...
保存先:
| 出版年: | Retina |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452434/ https://ncbi.nlm.nih.gov/pubmed/25932553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000000606 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|